TSEN15
tRNA-splicing endonuclease subunit Sen15
Also known as: C1orf19, SEN15_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WW01
- Gene
- TSEN15
- Ensembl
- ENSG00000198860
- Chromosome
- 1
- Canonical length
- 171 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a subunit of the tRNA splicing endonuclease, which catalyzes the removal of introns from tRNA precursors. Alternative splicing results in multiple transcript variants. There is a pseudogene of this gene on chromosome 17. [provided by RefSeq, Jul 2014]
Canonical amino-acid sequenceUniProt
171 residues, UniProt reviewed canonical sequence.
>Q8WW01|TSEN15
1 MEERGDSEPT PGCSGLGPGG VRGFGDGGGA PSWAPEDAWM GTHPKYLEMM ELDIGDATQV
61 YVAFLVYLDL MESKSWHEVN CVGLPELQLI CLVGTEIEGE GLQTVVPTPI TASLSHNRIR
121 EILKASRKLQ GDPDLPMSFT LAIVESDSTI VYYKLTDGFM LPDPQNISLR RLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TSEN15 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 40 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 40 nTPM
- skeletal muscle: 34 nTPM
- midbrain: 28 nTPM
- epididymis: 26 nTPM
- thymus: 26 nTPM
- heart muscle: 25 nTPM
Single-cell type
- oligodendrocytes: 99 nCPM
- podocytes: 81 nCPM
- myonuclei: 78 nCPM
- choroid plexus epithelial cells: 68 nCPM
- plasma cells: 66 nCPM
- differentiating spermatogonia: 65 nCPM
Immune cell
- NK-cell: 55 nTPM
- T-reg: 40 nTPM
- myeloid DC: 36 nTPM
- memory CD8 T-cell: 35 nTPM
- total PBMC: 35 nTPM
- gdT-cell: 34 nTPM
Brain region
- white matter: 61 nTPM
- cerebral cortex: 51 nTPM
- medulla oblongata: 50 nTPM
- basal ganglia: 48 nTPM
- hypothalamus: 48 nTPM
- thalamus: 47 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TSEN15.
Disease | AllUniProt
Conditions TSEN15 is implicated in, by any mechanism.
- Pontocerebellar hypoplasia 2F (PCH2F) MIM:617026
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 67 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Pontocerebellar hypoplasia, type 2F
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.8
- gnomAD pLI
- 0.28
- gnomAD missense Z
- 1.17
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 12% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- tRNA endonuclease-like domain superfamily
- tRNA intron endonuclease, catalytic domain-like superfamily
- tRNA-splicing endonuclease subunit Sen15
- Sen15 protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TSEN15 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TSEN15 as an antibody target. Whether an autoantibody or antibody against TSEN15 could matter depends on whether native TSEN15 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TSEN15 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TSEN15 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...